Drug Safety Newsletter 5th Edition
31 October 1997
Topics Covered:
Adverse Reaction Reporting by Companies, Augmentin, Clinical Trial Adverse Event/Reaction Reports, Co-Amoxiclav, Dexfenfluramine, Didanosine, Epivir, Fenfluramine, Hivid, Lamisil, Lamivudine, Malathion, Nucleoside Analogues , Oral Contraceptives, Periodic Safety Update Reports, Retrovir, Sabril, Stavudine, Terbinafine, Videx, Vigabatrin, Vitamin B6, Zalcitabine, Zerit, Zidovudine
Click Here Drug Safety Newsletter 5th Edition to read more on the above topics.